Apr 27, 2023

Featuring perspectives from Dr Sara A Hurvitz, including the following topics:

• Introduction: Antibody-Drug Conjugates in Breast Cancer (0:00)
• Case: A premenopausal woman in her late 40s with 0.8-cm ER/PR-positive, HER2-negative invasive ductal carcinoma (IDC) with 2 positive nodes and an Oncotype DX® Recurrence...

Apr 26, 2023

Featuring perspectives from Drs Robert L Coleman, Matthew A Powell and Brian M Slomovitz, moderated by Dr Shannon N Westin, including the following topics:

• Immune Checkpoint Inhibitors for Patients with Advanced Microsatellite Instability (MSI)-High/Mismatch Repair (MMR)-Deficient Endometrial Cancer — Dr Powell 

Apr 21, 2023

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes — Faculty Presentation 2: Myelodysplastic Syndromes — Dr Uma Borate, MD, MS

CME information and select...

Apr 21, 2023

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes — Faculty Presentation 1: Acute Myeloid Leukemia — Prof Andrew H Wei

CME information and select...

Apr 21, 2023

Featuring perspectives from Dr Uma Borate and Prof Andrew Wei, including the following topics:

• Introduction (0:00)
• Acute Myeloid Leukemia (AML): Key Papers and Presentations (3:30)
• Myelodysplastic Syndromes (MDS): Key Papers and Presentations (36:32)

CME information and select...